Generic Name and Formulations:
Carisoprodol 200mg, aspirin 325mg; tabs.
Various generic manufacturers
- Once-Daily Rivaroxaban 15 mg to 20 mg Increases Intracranial Hemorrhage Risk
- Alteplase Non-Superior to Aspirin for Improving 90-Day Functional Outcome in Acute Ischemic Stroke
- Diclofenac Use Slows Cognitive Decline in Alzheimer Disease
Indications for Carisoprodol/Aspirin:
Painful musculoskeletal conditions.
1–2 tabs 4 times daily.
NSAID allergy. Varicella or influenza in teenagers. Coagulation disorders. Porphyria.
Peptic ulcer. Gastritis. Renal or hepatic dysfunction. Drug abuse. Monitor blood pressure, BUN, uric acid levels. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Muscle relaxant (central) + salicylate.
Alcohol, CNS depressants, oral anticoagulants, hypoglycemics, and plasma bound drugs (e.g., methotrexate) potentiated. NSAIDs, corticosteroids and oral anticoagulants increase risk of GI bleeding. Uricosurics antagonized. Urine alkalinizers or acidifiers decrease or increase, respectively, plasma levels of aspirin.
Dizziness, drowsiness, GI upset or bleeding, rash, tachycardia, orthostatic hypotension. Rare idiosyncratic reaction (see literature).
Formerly known under the brand name Soma Compound.
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Ozanimod Reduces Severe Relapses in Multiple Sclerosis More Than Interferon Beta-1a